Investor Relations

Home > Investor Relations > Financial Highlights (consolidated)

Financial Highlights (consolidated)

Change of Principal Management Figures

Settlement of accounts time FY2007
(2007/4/1-2008/3/31)
FY2008
(2008/4/1-2009/3/31)
FY2009
(2009/4/1-2010/3/31)
FY2010
(2010/4/1-2011/3/31)
Net sales
(million yen)
31,495 35,966 39,043 46,145
Operating income
(million yen)
5,285 6,408 7,744 9,654
Ordinary income
(million yen)
5,146 6,682 7,430 9,396
Net income
(million yen)
2,692 3,777 4,601 5,846
Total shareholders' equity
(million yen)
34,938 38,045 41,945 46,664
Total assets
(million yen)
45,066 48,238 60,504 72,964
Shareholders' equity per share
(yen)
2,035.11 2,216.14 2,443.36 2,718.23
Net income per share
(yen)
156.85 220.02 268.07 340.58
Shareholders' equity ratio to total assets 77.5% 78.9% 69.3% 64.0%
Cash dividends per share
(yen)
45.00 45.00 55.00 65.00

Net Sales

Operating Income / Ordinary Income / Net Income

Net Income per Share / Cash Dividends per Share

Shareholders' Equity to Total Assets


Home > Investor Relations > Financial Highlights (consolidated)
© Copyright TOWA PHARMACEUTICAL CO.,LTD. All Rights Reserved.